$VRA SEC Filings

Filed On	Filing
21 Oct 2026	SCHEDULE 13G
07 Oct 2026	Form 4: Brockman Ivan, Director Bought 10,000 shares ($50.2K)
29 Sep 2026	Form 4: Brockman Ivan, Director Bought 2,500 shares ($10K)
15 Sep 2026	10-Q
15 Sep 2026	8-K: Results of Operations and Financial Condition Records second consecutive quarter of overall growth with FYQ2 consolidated net revenues up 1.1% to $71.6 million
24 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
07 Jul 2026	Form 4: Bickley Ian, Director Gave up 30,273 shares to cover exercise price or tax ($118K)
26 Jun 2026	Form 4: Dely Mark C, CHIEF ADMINISTRATIVE OFFICER Gave up 13,709 shares to cover exercise price or tax ($52.6K)
16 Jun 2026	Form 4: Bickley Ian, Director Bought 28,901 shares ($112K)
16 Jun 2026	Form 4: Layding Martin, Chief Financial Officer Gave up 43,365 shares to cover exercise price or tax ($150K)
16 Jun 2026	Form 4: Meslow Andrew, Director Bought 24,926 shares ($93K)
11 Jun 2026	10-Q
11 Jun 2026	8-K: Results of Operations and Financial Condition
10 Jun 2026	Form 4: Dely Mark C, CHIEF ADMINISTRATIVE OFFICER Gave up 3,919 shares to cover exercise price or tax ($12.1K) · Received 9,110 shares as a grant or award
09 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
29 May 2026	SD
24 Apr 2026	ARS
24 Apr 2026	Proxy statement: annual meeting on June 4, 2026 CEO pay $1.8M · say-on-pay vote
24 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Apr 2026	8-A12B/A

Comments